Latest Updates

Press releases

02 September 2020 | 19:01 PM CEST
First BioMimics 3D US Implant

Veryan Medical (Horsham, UK) has announced that Dr. Bret Wiechmann and his team at Vascular and Interventional Physicians in Gainesville, FL implanted the first commercial BioMimics 3D Vascular stent in the US, on the same day that the device was officially launched in the US. The BioMimics 3D self-expanding, nitinol stent features a highly differentiated, helical centre-line design that has achieved excellent clinical outcomes in clinical trials, including a pivotal study with 3-year follow-up, MIMICS-2.

01 September 2020 | 10:21 AM CEST
BioMimics 3D US launch

Veryan Medical (Horsham, UK) today announced that it has launched the innovative BioMimics 3D Vascular Stent System in the US. The BioMimics 3D self-expanding, nitinol stent features a highly-differentiated, helical centre-line design that has achieved excellent clinical outcomes in clinical trials, including a pivotal study with 3-year follow-up.

08 July 2020 | 15:54 PM CEST
Joint press release- Veryan & Walk Vascular -8th July 2020

Walk Vascular, LLC (Irvine, CA) and Veryan Medical (Horsham, UK) have announced that from today Veryan Medical will support Walk Vascular in the commercialization of the innovative JETi Peripheral Thrombectomy System in Germany.

09 June 2020 | 10:45 AM CEST
MIMICS-2 3-year data update

Professor Thomas Zeller (University Heart Centre Freiburg, Bad Krozingen, Germany) today presented the 36-month results from Veryan Medical’s MIMICS-2 study at CX 2020 Live.

13 December 2018 | 01:00 AM CET
December 2018

Otsuka Medical Devices and Veryan joint press release 13 Dec 2018

01 June 2018 | 02:00 AM CEST
June 2018

Veryan Medical press release on completion of MIMICS 3D enrollment. 20th June 2018

01 February 2018 | 01:00 AM CET
February 2018

BioMimics 3D PMA Submission Release 1.2.18

01 January 2018 | 01:00 AM CET
January 2018

MIMICS 2 12 month results.

01 September 2017 | 02:00 AM CEST
September 2017

Professor Thomas Zeller MD announces new significant outcomes from the Mimics Study

01 October 2016 | 02:00 AM CEST
October 2016

Veryan Medical announces the completion of subject enrolment into the MIMICS-2 clinical study of its BioMimics 3D® Self-Expanding Stent System. Enrolment in the MIMICS-2 study concluded with a total of 271 patients who were enrolled across 47 investigational sites in Germany, the USA and Japan.